Does Growth Hormone Cause Insulin Resistance? (The Real Answer)

Watch the full video on Rumble: https://rumble.com/v7gg5gq-does-growth-hormone-cause-insulin-resistance-the-real-answer.html

Growth Hormone and Insulin Resistance: What the Term Actually Means

The word "insulin resistance" gets used for two completely different things, and the confusion between them is why most conversations about growth hormone go sideways within about thirty seconds.

Here is the full chain before we zoom in. Growth hormone goes up, it tells fat cells to release stored fat into the bloodstream as free fatty acids, those fatty acids flood muscle and liver tissue, and when a cell is already swimming in fuel it stops reaching for more glucose. So blood sugar sits a little higher for a window of time. Then the fatty acids get burned or cleared, and the cell goes back to taking up glucose normally.

That is the whole mechanism, and the important part is that it is a fuel-switching event, not a broken receptor.

So at 2 IU, glucose uptake drops by roughly 39% in the hours after injection, but it clears within 5 hours. I cannot point you to a study that nails those exact numbers, so treat that as what I have seen rather than settled literature, but the shape of it is what matters more than the decimal places.

And that is mechanistically different from the pathological insulin resistance that leads to type 2 diabetes. The research hasn't drawn a clean line between the two in the way people assume it has, so I want to be careful here, but the distinction worth holding onto is between a cell that is temporarily full and a cell that has stopped listening.

Picture a parking garage that fills up completely on a Saturday afternoon, so cars start circling the block looking for a spot that doesn't exist yet. That crowded garage is not the same thing as a gate motor that has burned out and will not lift no matter how many cars line up. One problem resolves on its own once enough cars leave and the spaces open back up, and the other sits there broken until somebody takes it apart and fixes the mechanism.

Pathological insulin resistance is the broken gate, built over years of chronic calorie excess and visceral fat accumulation and the inflammation that comes with it, and it does not clear in five hours because nothing about it is a short-term fuel signal.

And so I think the big confusion around growth hormone is we're kind of wrapping this term insulin resistance into this big package and just throwing it on the top of growth hormone use. The word carries all the weight of a diabetes diagnosis, so the moment someone hears it attached to growth hormone, they imagine the long-term version.

Here is the test I use to check whether someone's belief is internally consistent.

If you believe that a low dose of say 1-2 IU of growth hormone per day causes insulin resistance, then the same thing would also apply to you adding CJC and tesamorelin. I have seen almost nobody apply that standard evenly, and no study has shown me a clean version of either side of it, but the logic has to hold in both directions or it is not logic. Those peptides work by raising your own growth hormone output, and that output is the identical hormone your body already makes, triggering the identical release of fatty acids downstream and the identical brief dip in how readily cells take up glucose.

But there's a big difference between a reduction in glucose uptake post-injection for a short period of time and long-term resistance causing type 2 diabetes.

There is also the other side of the ledger, which nobody puts in the equation. Less visceral fat and more lean mass both push insulin sensitivity in the right direction, so if growth hormone use changes your body composition over months, that change is working against the acute effect, not alongside it.